This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

NOI to Sole Source to QuVa Pharma, Inc.

Closed

NOI-OD-26-000038Federal

Submission Closed05/06/2026, 01:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Chlorine Dioxide Water Purification Tablets

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Kerlix Gauze Bandages (NSN 6510-00-058-3047)

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0189

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROXYPROPYL METHYLCE

Solicitation # SPE2DP-27-T-0185

Solicitation SPE2DP-27-T-0185 is a Small Business Set-Aside request for the procurement of Ocucoat Viscoelastic 1ML, a 2% hydroxypropyl methylcellulose ophthalmic solution (NSN 6505016331037). This FDA-regulated medical device is designed for high-volume, small-incision cataract surgery and lens inserter lubrication. The requirement consists of 5 boxes, with a delivery timeline of 79 days after receipt of order and an original required delivery date of October 27, 2026. Delivery is FOB Destination, with the final destination located at the USA Med Mat Ctr EUR in Kaiserslautern, Germany. The contract mandates strict quality and shelf-life compliance, requiring a non-extendable shelf life of 24 months per RS016. Packaging must be commercial and sealed to prevent damage, adhering to MIL-STD-2073-1E and DLA packaging requirements. Marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment. The procurement is subject to various DFARS and FAR clauses, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0186

Solicitation SPE2DP-27-T-0186, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of one bottle of Enrofloxacin Tablets (NSN 6509-01-487-5834). The medication is specified as 68 mg with a 7% concentration for veterinary use in dogs and cats, providing broad-spectrum antibacterial activity. The item is designated as Type I (Code Q) with a non-extendable shelf life of 36 months and must be stored at controlled room temperature. Delivery is required within 84 days after the date of order, with shipping terms set as FOB Destination to a facility in Kaiserslautern, Germany. The contract mandates strict adherence to quality and packaging standards, including MIL-STD-2073-1E, MIL-STD-129, and Medical Marking Standard No. 1. Special packaging instructions MPPWN00001 apply, and hazardous materials must be labeled according to the Hazard Communication Standard 29 CFR 1910.1200. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The procurement is subject to the Buy American and Balance of Payments Program (DFARS 252.225-7001) and requires compliance with cybersecurity reporting under DFARS 252.204-7012. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0188

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and SupplyThis subcontract for Pharmaceutical Manufacturing and Supply involves the production and delivery of specialized pharmaceutical preparations for prime contractors supporting the Department of Veterans Affairs. The scope of work encompasses the entire manufacturing lifecycle, including the compounding of pharmaceuticals, rigorous quality control testing, packaging, and labeling, with final delivery to VA facilities. To qualify, providers must maintain pharmaceutical grade manufacturing facilities and clean rooms, ensuring full FDA approval and strict adherence to current Good Manufacturing Practice compliance. This opportunity is managed under the Department of Veterans Affairs Network Contract Office 22 and is categorized under NAICS code 325412.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6505--VA Long Beach Pylarify

Solicitation # 36C26227Q0072

The Department of Veterans Affairs Long Beach Healthcare System intends to award a sole source, firm-fixed-price delivery order for Pylarify (piflufolastat F18) radiopharmaceutical injections. This advanced diagnostic imaging agent is utilized by the Nuclear Medicine department in conjunction with PET/CT scans to identify prostate-specific membrane antigen (PSMA) in prostate tumors, lymph nodes, bones, and other organs. The procurement is categorized under NAICS code 325412, Pharmaceutical Preparation Manufacturing, which has a size standard of 1,300 employees. The government has identified Progenics Pharmaceuticals, Inc. as the intended contractor, as the product is available under the VA National Acquisition Center Contract Federal Supply Schedule 36F79725D0093, effective from April 1, 2025, through March 31, 2030. This action is being conducted in accordance with RFO Part 8.401 and GSAM/R 538.7104-3(b)(ii) and 538.7104-4 regarding items peculiar to one manufacturer. While this is not a formal solicitation, interested parties capable of providing the same items may submit a capabilities statement to Contracting Specialist Melissa Ramirez by November 3, 2026, at 10:00 AM Pacific Local Time.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0181

Solicitation SPE2DP-27-T-0181 is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of five one-gallon bottles of USP Povidone-Iodine Cleansing Solution with a 7.5% active ingredient. This FDA-regulated product is for external use only and must be stored at 25 degrees Celsius, with permitted excursions between 15 and 30 degrees Celsius. The item has a total shelf life of 36 months, and at least 31 months of shelf life must remain upon delivery to the first government activity. Delivery is required within 20 days after receipt of the order, with a required delivery date of October 28, 2026, shipped FOB destination to the USS Ronald Reagan CVN 76. The contract mandates strict adherence to Medical Marking Standard No. 1 and DLA packaging requirements, including the use of sealed unit containers and commercial exterior shipping containers. Because the material may be hazardous, suppliers must provide Safety Data Sheets and labels compliant with the Hazard Communication Standard 29 CFR 1910.1200. Inspection and acceptance will occur at the destination. The procurement is governed by various FAR and DFARS clauses, including the Buy American Act, NIST SP 800-171 assessment requirements, and safeguarding of covered defense information. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0182

Solicitation SPE2DP-27-T-0182 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Isoniazid Tablets, NSN 6505001326904. The required product must be USP grade, 300 MG, and provided in bottles of 100 tablets. The procurement includes multiple line items, such as CLIN 0001 for one bottle and CLIN 0002 for eight bottles, with a required delivery date of October 28, 2026. Delivery is set as FOB Destination, with a delivery window of 20 days after receipt of order. Shipping destinations include the USNS Richard E Byrd and the USS Nitze. The contract mandates strict quality and storage standards, requiring the tablets to be kept at medical controlled room temperature with a non-extendable shelf life of 36 months. Packaging must comply with RP001 DLA requirements and MIL-STD-129, with specific adherence to Medical Marking Standard No. 1. If the material is deemed hazardous per FED-STD-313, TQ requirement IP025 applies; otherwise, commercial packaging per ASTM D3951 is required. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system. The solicitation is subject to various federal regulations, including the Buy American Act, DFARS cybersecurity reporting requirements, and prohibitions on covered defense telecommunications equipment.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0180

This procurement is a small business set-aside solicitation issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the supply of 12 units of Permethrin Cream Rinse (NSN 6505-01-256-4972). The product is an FDA-regulated drug consisting of a 1% W/V permethrin active ingredient provided in a 2 fl oz plastic squeeze bottle and must include a comb. The item has a total shelf life of 24 months, with a strict requirement that at least 21 months of shelf life remain upon receipt by the first government activity. Delivery is required within 20 days after receipt of order, with the destination point specified as the USS NITZE DDG 94, FPO AE 09579. The contract mandates strict adherence to medical marking and packaging standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129 for these acquisitions. Packaging must be commercial and sealed to protect contents from damage, with hazardous materials requiring compliance with 49 CFR, 29 CFR, and Safety Data Sheet (SDS) submissions per Federal Standard No. 313-E. Inspection and acceptance will occur at the destination. Administrative requirements include electronic invoicing via the Wide Area WorkFlow (WAWF) system and compliance with the Buy American Act and NIST SP 800-171 cybersecurity standards. Quotations are due by November 2, 2026, via the DIBBS portal.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Product SupplyThis subcontract for the Department of Veterans Affairs National CMOP Office involves the supply of pharmaceutical products to prime contractors. The agreement mandates that all products feature distinct 11-digit NDCs and maintain expiration dates of more than 12 months from the date of delivery. To maintain quality control, shipments are limited to a maximum of three lot numbers and must include 100cc bottles with child safety caps and unit-of-use packaging. The supplier is required to provide OEM documentation and strictly adhere to regulations regarding Counterfeit Items and Gray Market products. All deliveries must be accompanied by appropriate packing slips. Performance for this contract takes place in Ladson, South Carolina, under NAICS code 325412.

National Cmop Office (36C770)

POSTED

2 days ago

DEADLINE

in 1 day

AI Contract Overview

The National Institutes of Health plans to award a one-year, firm-fixed-price sole source contract to QuVa Pharma, Inc. for the purchase of 503b-compounded intravenous narcotics essential for patient care at the NIH Clinical Center in Bethesda, Maryland. Market research identified QuVa Pharma as the only U.S. manufacturer and distributor of these specialized IV narcotics, with no alternative suppliers capable of meeting the clinical requirements, justifying a non-competitive acquisition under FAR 6.302-1. This action is conducted under Simplified Acquisition Procedures (FAR Part 13), which exempts it from full and open competition requirements due to the uniqueness of the product and the limited market. The total estimated value of the contract is $684,000 over five years, including one base year valued at $110,000 and four optional years. Delivery and performance are required exclusively at the NIH Clinical Center, with inspection and acceptance managed by the government’s Contracting Officer’s Representative. The contract relies on QuVa Pharma’s FDA-registered 503b compounding status to ensure compliance with federal pharmaceutical standards, though detailed packaging, labeling, preservation, or inspection protocols are not specified in the documentation. No solicitation will be issued, and no formal competitive evaluation factors, pricing breakdowns, or clause attachments are required or provided beyond the statutory justification for sole source procurement. Public comments on the intent to award are being accepted until May 6, 2026, but the government retains sole discretion to proceed without competition.

General Info

NIH awards sole-source $110K contract to QuVa Pharma for IV narcotics at Clinical Center, with five-year potential.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

JOFOC for 503B IV Narcotics Purchase NIH Clinical Center

justification-and-authorization

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedMay 1

Presolicitation

Response DeadlineMay 6

Deadline has passed

Submission Closed

05/06/2026, 01:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao

Office AddressBETHESDA, MD, 20892, USA

Contacts

Huda Malik

contact@example.gov

Full Description

The purpose of this acquisition is to purchase 503b compounded Intravenous (IV) Narcotics for patient care. Market research has been conducted with only two responses, from QUVA, the known Compounder and distributor for these IV narcotics. Through trade shows, continuous learning seminars and trade journals, the CC Pharmacy Department stays abreast of the industry and is current on the availability of singular distribution outlets for these medications.

• Product Service Code: 6515 – Medical and Surgical Instruments, Equipment, and Supplies

• NAICS Code: 325412 – Pharmaceutical Preparation Manufacturing

• Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA

POTS: 26-000038

Description:

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a one-year contract to QuVa Pharma, Inc., located at 3 Sugar Creek Center Boulevard, Sugarland, TX 77478, on a firm fixed price sole source award basis for the purchase of 503b compound Intravenous (IV) Narcotics for patient care.

The proposed vendor, QuVa Pharma Inc., is the Original Manufacturer and has not designated other distributors of IV narcotics in the U.S.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Huda Malik, Contract Specialist via email to contact@example.gov by May 6, 2026 at 9 am EST.